Almac Discovery Ltd. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Almac Discovery Ltd. - Product Pipeline Review - 2014" provides data on the Almac Discovery Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Almac Discovery Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Almac Discovery Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Almac Discovery Ltd. - Brief Almac Discovery Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Almac Discovery Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Almac Discovery Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Almac Discovery Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Almac Discovery Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Almac Discovery Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Almac Discovery Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Almac Discovery Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Almac Discovery Ltd. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Almac Discovery Ltd. Snapshot 5
Almac Discovery Ltd. Overview 5
Key Information 5
Key Facts 5
Almac Discovery Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Almac Discovery Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Almac Discovery Ltd. - Pipeline Products Glance 10
Almac Discovery Ltd. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Almac Discovery Ltd. - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Almac Discovery Ltd. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Almac Discovery Ltd. - Drug Profiles 14
granisetron 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ALM-201 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
AD-01 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ALM-301 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecule Targeting DNA for Oncology 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule to Inhibit WEE-1 for Cancer 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecules to Modulate Deubiquitinating Enzymes for Cancers 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Almac Discovery Ltd. - Pipeline Analysis 21
Almac Discovery Ltd. - Pipeline Products by Therapeutic Class 21
Almac Discovery Ltd. - Pipeline Products by Target 22
Almac Discovery Ltd. - Pipeline Products by Route of Administration 23
Almac Discovery Ltd. - Pipeline Products by Molecule Type 24
Almac Discovery Ltd. - Pipeline Products by Mechanism of Action 25
Almac Discovery Ltd. - Recent Pipeline Updates 26
Almac Discovery Ltd. - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29

List of Tables
Almac Discovery Ltd., Key Information 5
Almac Discovery Ltd., Key Facts 5
Almac Discovery Ltd. - Pipeline by Indication, 2014 7
Almac Discovery Ltd. - Pipeline by Stage of Development, 2014 8
Almac Discovery Ltd. - Monotherapy Products in Pipeline, 2014 9
Almac Discovery Ltd. - Phase III, 2014 10
Almac Discovery Ltd. - Phase I, 2014 11
Almac Discovery Ltd. - Preclinical, 2014 12
Almac Discovery Ltd. - Discovery, 2014 13
Almac Discovery Ltd. - Pipeline by Therapeutic Class, 2014 21
Almac Discovery Ltd. - Pipeline by Target, 2014 22
Almac Discovery Ltd. - Pipeline by Route of Administration, 2014 23
Almac Discovery Ltd. - Pipeline by Molecule Type, 2014 24
Almac Discovery Ltd. - Pipeline Products by Mechanism of Action, 2014 25
Almac Discovery Ltd. - Recent Pipeline Updates, 2014 26